Targeting Signal Transducer and Activator of Transcription Signaling Pathway in Leukemias
AUTOR(ES)
Benekli, Mustafa
FONTE
American Society of Clinical Oncology
RESUMO
Signal transducer and activator of transcription (STAT) proteins comprise a seven-member family of latent cytoplasmic transcription factors that are activated through tyrosine phosphorylation by a variety of cytokines and growth factors. Aberrant activation of STATs accompanies malignant cellular transformation with resultant leukemogenesis. Constitutive activation of STATs has been demonstrated in various leukemias. A better understanding of the mechanisms of dysregulation of the STAT pathway and understanding of the cause and effect relationship in leukemogenesis may serve as a basis for designing novel therapeutic strategies directed against STATs. Mechanisms of STAT activation, the potential role of STAT signaling in leukemogenesis, and recent advances in drug discovery targeting the STAT pathway are the focus of this review.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2744278Documentos Relacionados
- Constitutive activation of an epithelial signal transducer and activator of transcription (STAT) pathway in asthma
- Influence of Signal Transducer and Activator of Transcription-1 Signaling on Thyroid Morphology and Function
- Signal transducer and activator of transcription 4 limits the development of adaptive regulatory T cells
- Expression of activated signal transducer and activator of transcription-3 predicts poor prognosis in cervical squamous-cell carcinoma
- Guggulsterone enhances head and neck cancer therapies via inhibition of signal transducer and activator of transcription-3